ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

REGN Regeneron Pharmaceuticals Inc

1 045,69
19,14 (1,86%)
15 Juin 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 353 917
Prix Achat 1 036,87
Prix Vente 1 046,00
Actualités (1)
Maximum Haut 1 042,66

Bas
684,805

Sur 52 semaines

Haut
1 042,66

Minimum Bas 1 028,285
Nom Action Symbole Action Marché Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
19,14 1,86% 1 045,69 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1 024,30 1 028,285 1 042,66 1 036,52 1 026,55
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
16 560 353 917 US$ 1 034,70 US$ 366 196 964 - 684,805 - 1 042,66
Dernière Transaction Type Quantités échangées Prix transaction Devise
01:46:16 1 US$ 1 044,78 USD

Flux d'options Regeneron Pharmaceuticals (REGN)

Flux global

Haussier

Prime nette

2M

Calls / Puts

800,00%

Ach. / Vent.

66,67%

OTM / ITM

50,00%

Sweeps Ratio

0,00%

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
113,77B 109,76M - 13,12B 3,95B 36,02 28,78
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Regeneron Pharmaceuticals

Date Heure Source Titre
14/6/202422:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
13/6/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/6/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/6/202413:00GlobeNewswire Inc.Kevzara® (sarilumab) Approved by FDA for the Treatment of..
10/6/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/6/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/6/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/6/202420:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securities

Forum Action Regeneron Pharmaceuticals

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Regeneron Pharmaceuticals Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine999,001 042,66992,221 015,61343 59346,694,67%
1 mois969,271 042,66952,30992,20383 91376,427,88%
3 mois973,001 042,66875,225949,48427 11372,697,47%
6 mois873,811 042,66838,455936,78495 118171,8819,67%
1 an766,071 042,66684,805858,08514 634279,6236,50%
3 ans525,621 042,66516,75717,87634 241520,0798,94%
5 ans306,811 042,66271,37596,76761 045738,88240,83%

Dernières Valeurs Consultées

Delayed Upgrade Clock